A UAB-developed automated online weight loss program helps cancer survivors achieve the highest weight loss ever reported for a digital intervention, improving cardiometabolic health, diet quality and ...
Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.
In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...
Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.
A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...
Because for most people, eating well isn’t hard in theory. It’s hard in the accumulation of choices. Breakfast, lunch, snacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results